Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
Join Avery in the Don’t Talk-A-Thon
Wondering how the Don’t Talk-A-Thon came to be? It all started with then 9-year-old Avery Niedrowski! After her grandfather was diagnosed with ALS, he lost